Abstract:To the Editor: We read with great interest the recently published article by Broersen et al.1 This study demonstrated the significant association between hs-cTnT (high-sensitivity cardiac troponin T) in patients with mild-to-moderate first-ever ischemic stroke without dementia and high prevalence of cognitive impairment at baseline and during 3-year follow-up. Recently, there has been much interest in the association of elevated cTnT, a specific biomarker for myocardial injury, with cognitive impairment. The ARIC study (Atherosclerosis Risk in Communities) found that people in communities with elevated hs-cTnT at baseline had lower cognitive scores at baseline and increased risk of dementia hospitalization during follow-up.2 Coronary heart disease was also associated with accelerated cognitive decline.3 These studies show that subclinical myocardial injury may be associated with cognitive decline. For patients with mild-to-moderate first-ever ischemic stroke without dementia, similar results were found. These patients with elevated hs-cTnT at admission baseline had lower cognitive function scores and more significant cognitive impairment during follow-up. Authors proposed 3 possible underlying mechanisms for this result. First, heart disease may cause ischemic stroke. Second, stroke-heart syndrome impaired autonomic cardiac function with myocardial damage after stroke. Finally, common vascular risk factors may lead to damage of both organs simultaneously as small vessel disease. Although authors perfectly explained why patients with first-ever ischemic stroke have increased hs-cTnT, they did not explain why elevated hs-cTnT was associated with worse cognitive function at baseline and during follow-up. Unlike that in community populations, cognitive decline in patients with ischemic stroke may be influenced by more factors. For example, cardiogenic infarction may be larger and more acute and may cause severer cognitive deficiency. Patients with heart diseases may continuously shed small thrombus, which can result in brain damage and cognitive impairment. Heart failure and usage of beta-blockers may reduce the cardiac output, which can decrease the cerebral blood flow and cause white matter lesions.4 Another possible mechanism for elevated hs-cTnT in stroke patients with cognitive decline may be related to the shared risk factors. Elevated hs-cTnT levels in patients with stroke were associated with impaired cognitive function at baseline (RR, 1.66 [95% CI, 1.26– 2.17]). After adjusting for major vascular risk factors, the association became insignificant (RR, 1.20 [95% CI, 0.89–1.62]). Common vascular risk factors, such as age, sex, obesity, smoking, alcohol consumption, cysteinemia, hypertension, hyperlipidemia, and diabetes mellitus have been associated with cognitive impairments.

Cognitive Impairment after Ischemic Stroke: Pathophysiological Mechanisms and Predictors

Correlation of Posterior Cerebral Artery Ischemic Stroke and Cognitive Impairment

Risk Factors for Early-Stage Cognitive Deterioration after Ischemic Stroke

Risk factors and predictive markers of post-stroke cognitive decline–A mini review

Relatedl Factors of Cognitive Impairment after Stroke

The Current Status and Progress on Risk Factors of Cognitive Impairment after Stroke

Post-stroke Cognitive Impairment: Epidemiology, Mechanisms and Management.

Assessment of cognitive dysfunction and its influencing factors after acute ischemic stroke

Progress in poststroke cognitive impairment

Post-Stroke Cognitive Impairment: Pathophysiological Insights into Brain Disconnectome from Advanced Neuroimaging Analysis Techniques

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Frequency and Risk Factors of Vascular Cognitive Impairment Three Months after Ischemic Stroke in China: The Chongqing Stroke Study

Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.

[The Prevalence and Risk Factors for Cognitive Impairment Following Ischemic Stroke].

Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options

Advances in Serological Biomarkers and Imaging to Predict Post-Stroke Cognitive Impairment

EEG biomarkers analysis in different cognitive impairment after stroke: an exploration study

[The Evolution of Cognition and Its Influence Factors after Stroke].

The role of ventral hippocampal-medial prefrontal glutamatergic pathway on the non-affected side in post-stroke cognitive impairment

Letter by Xu Et Al Regarding Article, "High-Sensitivity Cardiac Troponin T and Cognitive Function in Patients with Ischemic Stroke".

Predictors for Vascular Cognitive Impairment in Stroke Patients